2025 · 1st Quarter (Jan 1 - Mar 31)

RAFA LABORATORIES, LTD

Filed by MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M & W GOVERNMENT AFFAIRS, LLC).

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 22, 2025
Income: $50,000.00
Expenses: Not reported
Registrant: MILNE, WIENER & SHOFE GLOBAL STRATEGIES (FKA M & W GOVERNMENT AFFAIRS, LLC)
Client: RAFA LABORATORIES, LTD
Filing UUID: 981d5e88-88ef-4a52-bb19-ab141793cf4f
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Advocacy for the inclusion of Midazolam Autoinjectors and Atropine Autoinjectors in the Strategic National Stockpile

DEF · Defense

Advocating for the procurement of midazolam autoinjectors and atropine autoinjectors for the Department of Defense

BUD · Budget/Appropriations

Advocacy for the inclusion of Midazolam Autoinjectors and Atropine Autoinjectors in the Strategic National Stockpile, as well as for procurement by of the same autoinjectors by the Department of Defense. Advocated for procurement in the FY25 Continuing Resolution and the upcoming FY26 Approprations process.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.